Search by Drug Name or NDC
NDC 00254-3012-55 ALVIMOPAN 12 mg/1 Details
ALVIMOPAN 12 mg/1
ALVIMOPAN is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is ALVIMOPAN.
MedlinePlus Drug Summary
Alvimopan is used to help the bowel recover more quickly after bowel surgery, so that you can eat solid foods and have regular bowel movements. Alvimopan is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the constipation effects of opioid (narcotic) medications that are used to treat pain after surgery.
Related Packages: 00254-3012-55Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Alvimopan
Product Information
| NDC | 00254-3012 |
|---|---|
| Product ID | 0254-3012_995ea3be-a86b-4dc7-ac69-fcc4af5fa781 |
| Associated GPIs | |
| GCN Sequence Number | 064325 |
| GCN Sequence Number Description | alvimopan CAPSULE 12 MG ORAL |
| HIC3 | H3Y |
| HIC3 Description | MU-OPIOID RECEPTOR ANTAGONISTS,PERIPHERALLY-ACTING |
| GCN | 13285 |
| HICL Sequence Number | 035795 |
| HICL Sequence Number Description | ALVIMOPAN |
| Brand/Generic | Generic |
| Proprietary Name | ALVIMOPAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ALVIMOPAN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 12 |
| Active Ingredient Units | mg/1 |
| Substance Name | ALVIMOPAN |
| Labeler Name | Par Pharmaceutical, Inc. |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216843 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00254-3012-55 (00254301255)
| NDC Package Code | 0254-3012-55 |
|---|---|
| Billing NDC | 00254301255 |
| Package | 6 BLISTER PACK in 1 CARTON (0254-3012-55) / 5 CAPSULE in 1 BLISTER PACK |
| Marketing Start Date | 2023-05-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |